Densearn (@densearn) profile picture

Densearn

@densearn

CEO, Gravida Health | Clinical Commercialisation Expert

linkedin.com/in/densearn/
Joined October 2017
  • Tweets34
  • Following154
  • Followers28
Densearn retweeted
The BMJ (@bmj_latest) profile picture
The BMJ
@bmj_latest3 May 2020
Use of sodium glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, finds a new study ow.ly/Nal850zqpzC @PeterUeda1
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian...

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian...

Objective To assess the association between use of sodium-glucose co-transporter 2 (SGLT2) inhibitors and risk of serious renal events in data from routine clinical practice. Design Cohort study...

bmj.com
18
1
35
Load more